Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours (Q85753272)

From Wikidata

Jump to navigation Jump to search

scientific article published on 13 September 2013

edit

Language	Label	Description	Also known as
English	Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours	scientific article published on 13 September 2013

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

title

Outcome and toxicity of salvage therapy with 177Lu-octreotate in patients with metastatic gastroenteropancreatic neuroendocrine tumours (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

main subject

lutetium-177

1 reference

based on heuristic

inferred from title

author

Hojjat Ahmadzadehfar

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

author name string

Amir Sabet

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Torjan Haslerud

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Ulrich-Frank Pape

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Amin Sabet

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Frank Grünwald

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Stefan Guhlke

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Hans-Jürgen Biersack

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Samer Ezziddin

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

publication date

13 September 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

European Journal of Nuclear Medicine and Molecular Imaging

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

volume

41

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

issue

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

page(s)

205-210

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

cites work

Treatment with (90)Y- and (177)Lu-DOTATOC in patients with metastatic neuroendocrine tumors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0),Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

End-stage renal disease after treatment with 90Y-DOTATOC.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-Term Survival, Toxicity Profile, and role of F-18 FDG PET/CT scan in Patients with Progressive Neuroendocrine Tumors Following Peptide Receptor Radionuclide Therapy with High Activity In-111 Pentetreotide

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term efficacy of high-activity 111in-pentetreotide therapy in patients with disseminated neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term toxicity of [(177)Lu-DOTA (0),Tyr (3)]octreotate in rats

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: a clinical phase II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

From outside to inside? Dose-dependent renal tubular damage after high-dose peptide receptor radionuclide therapy in rats measured with in vivo (99m)Tc-DMSA-SPECT and molecular imaging

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Measurement of glomerular filtration rate: single injection plasma clearance method without urine collection

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptor radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of peptide receptor radionuclide therapy with [In-DTPA]octreotide: the Rotterdam experience

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated radionuclide therapy with 90Y-DOTATOC in association with amino acid infusion: a phase I study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indium-111-pentetreotide prolongs survival in gastroenteropancreatic malignancies

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of patients with gastro-entero-pancreatic (GEP) tumours with the novel radiolabelled somatostatin analogue [177Lu-DOTA(0),Tyr3]octreotate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overview of results of peptide receptor radionuclide therapy with 3 radiolabeled somatostatin analogs.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Yttrium-90 DOTATOC: first clinical results

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptor radionuclide therapy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment with 177Lu-DOTATOC of patients with relapse of neuroendocrine tumors after treatment with 90Y-DOTATOC.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Somatostatin receptor-targeted radionuclide therapy in patients with gastroenteropancreatic neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Receptor-mediated radiotherapy with Y-DOTA-DPhe-Tyr-octreotide: the experience of the European Institute of Oncology Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Response and long-term control of bone metastases after peptide receptor radionuclide therapy with (177)Lu-octreotate

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteria

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Peptide receptor radionuclide therapy with ¹⁷⁷Lu-DOTATATE: the IEO phase I-II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Salvage therapy with (177)Lu-octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/24030668

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/S00259-013-2547-Z

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

Dimensions Publication ID

1035024804

0 references

PubMed publication ID

24030668

1 reference

stated in

Europe PubMed Central

PubMed publication ID

24030668

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24030668%20AND%20SRC:MED&resulttype=core&format=json

retrieved

21 February 2020

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q85753272&oldid=2249122477"